Multiple Cold and Flu Medications Recalled Due to Improper Storage Conditions
Family Dollar Stores is recalling multiple cold and flu medications distributed April 30–June 10, 2022, because products were held outside appropriate storage temperature conditions.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Medications are inherently risk-of-harm products where storage conditions directly affect safety and efficacy. The FDA's Class II classification indicates potential for temporary or medically reversible adverse health consequences. Temperature deviations can cause degradation or reduced potency. While no illnesses have been reported, the potential harm from temperature-affected medications warrants High severity.
Plain-English summary
Family Dollar Stores is recalling multiple cold and flu medications that were distributed to specific Family Dollar Stores between April 30, 2022 and June 10, 2022. The recalled products include various formulations of DayQuil, Nyquil, Alka-Seltzer Plus, Robitussin, Good Sense, and Aspirin cold and flu relief products, available in liquids, soft gels, and capsules.
The recall was issued because the products were held outside appropriate storage temperature conditions during distribution. This storage deviation violates current Good Manufacturing Practices (CGMP), which establish standards for maintaining product integrity and safety.
The affected products are identified by specific SKU numbers listed in the official FDA recall notice. Consumers who purchased cold and flu medications from Family Dollar Stores during the specified distribution period should check their product SKUs to determine whether they are affected.
Consumers with recalled products should contact Family Dollar Stores or the FDA for guidance on next steps, which may include returning the product, obtaining a replacement, or other remedial options.
The recalled product
- Product
- DAYQUIL COLD FLU LQD 12 FL OZ SKU 900205 RIC NIGHT TIME CLD FLU RLF SOFT GELS 8 CT SKU 900523 ALKA SELTZER PLUS DAY NIGHT LGEL 20 CT SKU 902012 GS COLD FLU RELIEF NGHTTIME CHRY12FL OZ SKU 917523 RIC COLD FLU DAY TIME LIQUID CAP 16 CT SKU 903037 ASP SEVERE COLD COUGH CI
- Manufacturer
- Family Dollar Stores, Llc.
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (14)
- SKUs: 900205
- 900523
- 902012
- 917523
- 903037
- 902906
- 902908
- 903333
- 903335
- 999542
- 903334
- 900576
- 903759
- 900207
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 100 recalled by Family Dollar Stores, Llc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 100 products in this recall →Related recalls
Same manufacturer · Family Dollar Stores, Llc.
See all →- ModerateFamily Dollar marijuana test strips recalled over improper storage
FDA (Devices) · 2023-11-15
- HighFamily Dollar Pregnancy Test Recalled Due to Improper Storage Conditions
FDA (Devices) · 2023-11-15
- ModerateFirst Response 2 CT Recalled for Improper Temperature Storage
FDA (Devices) · 2023-11-15
- ModerateFixodent Denture Cream Recalled Due to Improper Storage Conditions
FDA (Devices) · 2023-11-15
- ModerateOral B Mouth Sore Rinse Recall Due to Improper Storage Conditions
FDA (Devices) · 2023-11-15
Same hazard · improper storage temperature
See all →- HighPotato Salad Recalled for Improper Temperature Storage During Distribution
FDA (Food) · 2024-02-14
- ModeratePrescription drug SPIRIVA recalled for temperature storage deviation
FDA (Drugs) · 2024-01-03
- HighTopical ointment recall due to improper storage temperature conditions
FDA (Drugs) · 2022-08-31
- ModeratePain Reliever Caplets Recalled for Improper Storage Temperature
FDA (Drugs) · 2022-08-31
- ModerateBlistex Lip Medex Recalled Due to Improper Storage Conditions
FDA (Drugs) · 2022-08-31